Ji et al., 2018 - Google Patents
Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–Enhanced Herpes Simplex Virus Thymidine Kinase Gene TherapyJi et al., 2018
View HTML- Document ID
- 6205022698896459939
- Author
- Ji J
- Weng Q
- Zhang F
- Xiong F
- Jin Y
- Hui J
- Song J
- Gao J
- Chen M
- Li Q
- Shin D
- Yang X
- Publication year
- Publication venue
- Radiology
External Links
Snippet
Purpose To validate the feasibility and efficacy of intratumoral radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus (HSV) thymidine kinase (TK) and ganciclovir (GCV)(hereafter, HSV-TK/GCV) gene therapy for non–small-cell lung cancer (NSCLC) …
- 208000002154 Non-Small-Cell Lung Carcinoma 0 title abstract description 47
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
- A61B2018/183—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves characterised by the type of antenna
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Narayanan | Irreversible electroporation | |
| Ji et al. | Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–Enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy | |
| Carriero et al. | Ablative therapies for breast cancer: state of art | |
| Goldberg et al. | Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy | |
| Cuschieri et al. | Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumours | |
| Ulaner et al. | Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT | |
| Ruarus et al. | Irreversible electroporation in hepatopancreaticobiliary tumours | |
| Solazzo et al. | Liposomal doxorubicin increases radiofrequency ablation–induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways | |
| Huang et al. | Low-power laserthermia for the treatment of small hepatocellular carcinoma | |
| Kumar et al. | Targeting STAT3 to suppress systemic pro-oncogenic effects from hepatic radiofrequency ablation | |
| Campbell IV et al. | Advances in image-guided ablation therapies for solid tumors | |
| Chen et al. | Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor model | |
| Hui et al. | Advanced techniques in the percutaneous ablation of liver tumours | |
| Choi et al. | Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model | |
| Byrne et al. | Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors | |
| Shi et al. | Orthotopic esophageal cancers: intraesophageal hyperthermia-enhanced direct chemotherapy in rats | |
| Devun et al. | Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation | |
| Brem | Radiofrequency ablation of breast cancer: a step forward | |
| Wang et al. | Does thermosensitive liposomal vinorelbine improve end-point survival after percutaneous radiofrequency ablation of liver tumors in a mouse model? | |
| Heger et al. | Can local ablative techniques replace surgery for locally advanced pancreatic cancer? | |
| Chan et al. | Review on endobronchial therapies—current status and future | |
| Aycock et al. | Toward large ablations with single-needle high-frequency irreversible electroporation in vivo | |
| Sattar et al. | Current innovations in head and neck cancer: From diagnostics to therapeutics | |
| Wang et al. | 18F-FDG PET biomarkers help detect early metabolic response to irreversible electroporation and predict therapeutic outcomes in a rat liver tumor model | |
| Xu et al. | Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022) |